Skip Navigation


JAC Advance Access originally published online on November 22, 2005
Journal of Antimicrobial Chemotherapy 2006 57(1):52-60; doi:10.1093/jac/dki419
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/1/52    most recent
dki419v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Akiba, M.
Right arrow Articles by Zhang, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akiba, M.
Right arrow Articles by Zhang, Q.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni

Masato Akiba{dagger}, Jun Lin{ddagger}, Yi-Wen Barton and Qijing Zhang*

Department of Microbiology and Preventive Medicine, Iowa State University, Ames, IA 50011, USA

Received 15 August 2005; returned 21 September 2005; revised 11 October 2005; accepted 21 October 2005

* Corresponding author. Tel: +1-515-294-2038; Fax: +1-515-294-8500; E-mail: zhang123{at}iastate.edu

Objectives: To determine the role of CmeDEF in conferring antimicrobial resistance in Campylobacter jejuni and examine the interaction of CmeABC and CmeDEF in mediating antimicrobial resistance and maintaining cell viability.

Methods: Single and double mutants of cmeF and cmeB were generated in multiple strains using insertional mutagenesis. The mutants were compared with their wild-type strains for antimicrobial susceptibility and growth characteristics. Transcription fusion was used to quantify the expression of cmeDEF and cmeABC. Ethidium bromide (EB) accumulation assay was used to measure the efflux function.

Results: Insertional mutagenesis of the cmeF gene in C. jejuni NCTC 11168 resulted in a 2-fold decrease in the resistance to ampicillin, polymyxin B and EB, whereas the same mutation in C. jejuni 81-176 and 21190 led to a 2–4-fold increase in the resistance to multiple antimicrobials and toxic compounds. The increased resistance in the cmeF mutants of 81-176 and 21190 was associated with the elevated efflux in the mutants. Compared with the cmeB mutant, the cmeF/cmeB double mutants of 81-176 and 21190 showed further decrease in the resistance to various antimicrobials and toxic compounds. Transcription fusion assay indicated that the expression level of cmeF was substantially lower than that of cmeB. Notably, the cmeB/cmeF double mutation, not the single mutations, impaired cell viability in Campylobacter.

Conclusions: CmeDEF interacts with CmeABC in conferring antimicrobial resistance and maintaining cell viability in C. jejuni. CmeABC is the predominant efflux pump in C. jejuni, whereas CmeDEF plays a secondary role in conferring intrinsic resistance to antimicrobials.

Keywords: antibiotics , efflux , mutagenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
B. Jeon and Q. Zhang
Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter
J. Antimicrob. Chemother., May 1, 2009; 63(5): 946 - 948.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
B. Jeon and Q. Zhang
Cj0011c, a Periplasmic Single- and Double-Stranded DNA-Binding Protein, Contributes to Natural Transformation in Campylobacter jejuni
J. Bacteriol., October 15, 2007; 189(20): 7399 - 7407.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. Quinn, J.-M. Bolla, J.-M. Pages, and S. Fanning
Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection?
J. Antimicrob. Chemother., June 1, 2007; 59(6): 1230 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Lin, M. Yan, O. Sahin, S. Pereira, Y.-J. Chang, and Q. Zhang
Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in Chickens
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1678 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Yan, O. Sahin, J. Lin, and Q. Zhang
Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure
J. Antimicrob. Chemother., December 1, 2006; 58(6): 1154 - 1159.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Lin and A. Martinez
Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni
J. Antimicrob. Chemother., November 1, 2006; 58(5): 966 - 972.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.